Health News Roundup: Japan aims to fast-track review of anti-viral drug remdesivir; U.S. court dismisses New York nurses' plea for COVID-19 protection and more

Health News Roundup: Japan aims to fast-track review of anti-viral drug remdesivir; U.S. court dismisses New York nurses' plea for COVID-19 protection and more
Representative Image Image Credit: ANI

Following is a summary of current health news briefs.

Japan aims to fast-track review of anti-viral drug remdesivir

Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm's filing for such approval, the health minister said on Saturday. Health Minister Katsunobu Kato's comment comes after remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday.

U.S. hospitals promise new safety measures to ease patient fears after coronavirus crush

U.S. hospitals, many past the peak coronavirus crush, are relying on plexiglass dividers, advance testing of patients and limited elevator traffic to convince people, especially those needing urgent care, that the facilities are safe. Hospitals put lucrative elective procedures and other nonessential operations on hold weeks ago as they geared up for the coronavirus onslaught.

U.S. court dismisses New York nurses' plea for COVID-19 protection

A U.S. District Court on Friday dismissed a nurse association's plea against New York state and two hospitals to provide safety equipment and adopt measures to stop the spread of COVID-19 among its members, asking the parties to reach an amicable agreement. Last month, the New York State Nurses Association (NYSNA) sued the New York Department of Health, Montefiore Medical Center and the parent company of the Westchester Medical Center, saying the hospitals were ignoring requirements that healthcare workers each receive an N95 respirator mask daily, and that the health department was not enforcing it.

Harbin city shuts eateries, coronavirus curbs ease elsewhere in China

A northeastern Chinese city of 10 million people struggling with currently the country's biggest coronavirus cluster shut dine-in services on Saturday, as the rest of China eases restrictions designed to hamper the spread of the disease. Harbin, the provincial capital of Heilongjiang and its biggest city, said it temporarily suspended dine-in services for all eateries, reported the official CCTV citing an emergency epidemic prevention notice.

Russia's coronavirus cases hit new high, Moscow warns of clampdown

Russia reported 9,623 new cases of coronavirus on Saturday, its highest daily rise since the start of the pandemic, bringing the total to 124,054, mostly in the capital Moscow, where the mayor threatened to cut the number of travel permits. The death toll nationwide rose to 1,222 after 57 people died in the last 24 hours, Russia's coronavirus crisis response centre said, after revising the previous day's tally.

Indonesia reports 292 new coronavirus cases, 31 new deaths

Indonesia recorded 292 new coronavirus cases on Saturday, taking the total number of infections to 10,843, said health ministry official, Achmad Yurianto. Yurianto also reported 31 new deaths, taking the total number of fatalities to 831. The number of people who have recovered from COVID-19, the disease caused by the coronavirus, rose by 74 to 1,665, he said.

U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir

Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States. During a meeting in the Oval Office of the White House with President Donald Trump, Gilead Chief Executive Daniel O'Day called the move an important first step and said the company was donating 1.5 million vials of the drug to help patients.

Exclusive: U.S. coronavirus stimulus went to some healthcare providers facing criminal inquiries

Eager to bolster the healthcare system during the coronavirus pandemic, the U.S. government last month sped $30 billion in stimulus payments to most healthcare providers that billed Medicare last year. That speed resulted in taxpayers' money flowing to some companies and people facing civil or criminal fraud investigations, according to defense lawyers and others representing more than a dozen firms and people facing such inquiries.

Dutch coronavirus cases pass 40,000

The number of confirmed coronavirus infections in the Netherlands has increased by 445 to 40,236, Dutch health authorities said on Saturday. The National Institute for Public Health reported 94 new deaths, taking total COVID-19 fatalities to 4,987.

Iran coronavirus deaths rise by 65 to 6,156 as contamination slows

Iran's death toll from new coronavirus increased by 65 over the previous 24 hours to reach 6,156 on Saturday, Health Ministry spokesman Kianush Jahanpur said in a statement on state TV. The total number of diagnosed cases in Iran, one of the Middle Eastern countries hardest hit by the pandemic, has reached 96,448, up by 802 in the past 24 hours, the lowest daily increase rate in weeks, he said, adding that 2,787 were in critical condition.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.